Nicol, Phillip B.
Paulson, Danielle
Qian, Gege
Liu, X. Shirley http://orcid.org/0000-0003-4736-7339
Irizarry, Rafael http://orcid.org/0000-0002-3944-4309
Sahu, Avinash D. http://orcid.org/0000-0002-2193-6276
Funding for this research was provided by:
Foundation for the National Institutes of Health (R00CA248953)
Article History
Received: 14 December 2023
Accepted: 9 August 2024
First Online: 1 September 2024
Competing interests
: X.S.L. conducted the work while being on the faculty at DFCI, and is currently a board member and CEO of GV20 Therapeutics. P.B.N., D.P., G.Q., R.I., and A.D.S. declare no competing interests.